Pingyangmycin as a 99mTc carrier in tumor localization

Area of Science:

• Nuclear Medicine
• Radiochemistry
• Oncology

Background:

• Developing effective radiopharmaceuticals is crucial for accurate tumor detection.
• Pingyangmycin (PYM) is an antineoplastic agent with potential for use in diagnostic imaging.
• Optimizing labeling methods and understanding biodistribution are key for clinical application.

Purpose of the Study:

• To establish a simple and efficient method for preparing 99mTc-labeled pingyangmycin (99mTc-PYM) for clinical use.
• To investigate the effect of ascorbic acid on the biodistribution of 99mTc-PYM, particularly its uptake in tumors.
• To evaluate the preliminary clinical efficacy of 99mTc-PYM as a tumor-detecting tracer.

Main Methods:

• A simple labeling method using super-micro-amounts of SnCl2 as a reductant under dark conditions was developed.
• The labeling efficiency of 99mTc-PYM was determined.
• The biodistribution of 99mTc-PYM was studied with and without varying concentrations of ascorbic acid.
• Preliminary clinical trials were conducted in nine patients.

Main Results:

• The labeling efficiency of 99mTc-PYM was over 96%, requiring no further purification.
• Ascorbic acid increased the uptake of 99mTc-PYM in tumors, with increased tumor uptake correlating with higher ascorbic acid concentrations.
• Tumor-to-background ratios (tumor-blood, tumor-liver, tumor-lung) were favorable at 1.5 hours post-injection.
• Preliminary clinical trials demonstrated high sensitivity and specificity for tumor detection.

Conclusions:

• A simple, high-efficiency method for preparing 99mTc-PYM has been established.
• Ascorbic acid enhances tumor uptake of 99mTc-PYM, suggesting its utility in improving tumor visualization.
• 99mTc-PYM shows promise as a sensitive and specific tracer for clinical tumor detection.